Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Kakkar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2020
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)Andrea Marshall, Mark Levine, Catherine Hill, et al.
Drugs - Real World Outcomes|December 18, 2023
Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in IndiaKalyan Banerjee, Ajay Kakkar, Kashif Ahmed Shamsi, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Global public awareness about atrial fibrillationAaron M Wendelboe, Gary E Raskob, Pantep Angchaisuksiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancerGary H Lyman, Alok A Khorana, Anna Falanga, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Annie M Young, Andrea Marshall, Jenny Thirlwall, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2020
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)Andrea Marshall, Mark Levine, Catherine Hill, et al.
Drugs - Real World Outcomes|December 18, 2023
Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in IndiaKalyan Banerjee, Ajay Kakkar, Kashif Ahmed Shamsi, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Global public awareness about atrial fibrillationAaron M Wendelboe, Gary E Raskob, Pantep Angchaisuksiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancerGary H Lyman, Alok A Khorana, Anna Falanga, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Annie M Young, Andrea Marshall, Jenny Thirlwall, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
Pageof 3